Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy
A highly sensitive second-generation hepatitis C virus (HCV) core antigen assay has recently been developed. We compared viral disappearance and first-phase kinetics between commercially available core antigen (Ag) assays, Lumipulse Ortho HCV Ag (Lumipulse-Ag), and a quantitative HCV RNA PCR assay,...
Guardado en:
| Publicado en: | J Clin Microbiol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
2005
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC540104/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15634970/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.43.1.186-191.2005 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
